Combination treatment showed improved survival and tumor control in models of pancreatic ductal adenocarcinoma, implying potential clinical benefits.
Supplementary Figure S9: Effect of combination anti-PD-1 and RAS(ON) multiselective inhibition on body weight, tumor growth, and survival
No takes yet. Share an insight, caveat, or question.
Orlen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: